跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73,102 条关于
“aggressive B-cell lymphomas”
全部
73,102
临床试验
48,605
药物
6,448
机构
3,220
资讯
14,829
3个月前
Tafasitamab-Lenalidomide Combination Reduces Disease Progression Risk by 25% in High-Risk Aggressive B-Cell Lymphomas
去年
Ultrasensitive DNA Detection Shows Promise in B-Cell Lymphoma Remission Assessment
去年
Genmab's Epcoritamab Shows Promise in Diffuse Large B-Cell Lymphoma Trials
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
9个月前
Bantam Pharmaceutical Initiates First-in-Class BTM-3566 Phase 1 Trial for Aggressive Cancers
去年
Yescarta Approved in Scotland as First Second-Line CAR-T Therapy for DLBCL
2年前
Roche's Glofitamab Expands Treatment Horizons for Multiple B-Cell Lymphomas
9个月前
Foresight Diagnostics Showcases Ultrasensitive MRD Technology in Multiple Lymphoma Studies at ASH 2025
10个月前
Ryvu Therapeutics Presents Promising Clinical Data on Romaciclib and Dapolsertib at ASH 2025
3年前
FDA Approves Two Bispecific T-Cell Engagers for Relapsed/Refractory B-Cell Lymphomas
第 1 页，共 1483 页
上一页
下一页
